• William P. Levin
  • Thomas F. DeLaney
Part of the Medical Radiology book series (MEDRAD)


Soft tissue sarcomas are malignant tumors that arise in the mesoderm. There are over 50 subtypes of these tumors that vary greatly in biological behavior. While small, low-grade lesions may be adequately treated by resection alone; larger, higher-grade lesions require adjuvant therapy to maximize local control. We will examine the prognostic factors that predict for disease recurrence and the role of radiation therapy in this setting. We will also examine the toxicities associated with radiation, and how this information is utilized to help or guide decision making for the treatment of soft tissue sarcomas.


Local Recurrence Soft Tissue Sarcoma Positive Margin Regional Lymph Node Metastasis Soft Tissue Sarcoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



Soft tissue sarcoma


Second opinion


American Joint Committee on Cancer


Memorial Sloan-Kettering Cancer Center


Disease-free survival


Overall survival


University of Texas M. D. Anderson Cancer Center


Massachusetts General Hospital


The Princess Margaret Hospital


Regional lymph node metastases


Malignant peripheral-nerve tumor


Concordance index




General postoperative sarcoma nomogram from MSKCC


Disease-specific survival


Greater than or equal to 95 % necrosis


  1. Alektiar KM, Velasco J, Zelefsky MJ et al (2000) Adjuvant radiotherapy for margin-positive high-grade soft tissue sarcoma of the extremity. Int J Radiat Oncol Biol Phys 48:1051–1058PubMedCrossRefGoogle Scholar
  2. Arbiser ZK, Folpe AL, Weiss SW (2001) Consultative (expert) second opinions in soft tissue pathology. Analysis of problem-prone diagnostic situations. Am J Clin Pathol 116:473–476. doi: 10.1309/425H-NW4W-XC9A-005H PubMedCrossRefGoogle Scholar
  3. Behranwala KA, A’Hern R, Omar A-M, Thomas JM (2004) Prognosis of lymph node metastasis in soft tissue sarcoma. Ann Surg Oncol 11:714–719. doi: 10.1245/ASO.2004.04.027 PubMedCrossRefGoogle Scholar
  4. Biau DJ, Ferguson PC, Turcotte RE et al (2011) Adverse effect of older age on the recurrence of soft tissue sarcoma of the extremities and trunk. J Clin Oncol Official J Am Soc Clin Oncol 29:4029–4035. doi: 10.1200/JCO.2010.34.0711 CrossRefGoogle Scholar
  5. Cahlon O, Brennan MF, Jia X et al (2012) A postoperative nomogram for local recurrence risk in extremity soft tissue sarcomas after limb-sparing surgery without adjuvant radiation. Ann Surg 255:343–347Google Scholar
  6. Canter RJ, Beal S, Borys D et al (2010) Interaction of histologic subtype and histologic grade in predicting survival for soft-tissue sarcomas. J Am Coll Surg 210:191–198.e2. doi: 10.1016/j.jamcollsurg.2009.10.007 PubMedCrossRefGoogle Scholar
  7. Chan MF, Chui CS, Schupak K et al (2001) The treatment of large extraskeletal chondrosarcoma of the leg: comparison of IMRT and conformal radiotherapy techniques. J Appl Clin Med Phys/Am Coll Med Phys 2:3–8. doi: 10.1120/1.1322676 CrossRefGoogle Scholar
  8. Chibon F, Lagarde P, Salas S et al (2010) Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity. Nat Med 16:781–787. doi: 10.1038/nm.2174 PubMedCrossRefGoogle Scholar
  9. Dalal KM, Kattan MW, Antonescu CR et al (2006) Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk. Ann Surg 244:381–391. doi: 10.1097/01.sla.0000234795.98607.00 PubMedCentralPubMedGoogle Scholar
  10. Davis AM, O’Sullivan B, Turcotte R et al (2005) Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol J Eur Soc Ther Radiol Oncol 75:48–53CrossRefGoogle Scholar
  11. Delaney TF, Kepka L, Goldberg SI et al (2007) Radiation therapy for control of soft-tissue sarcomas resected with positive margins. Int J Radiat Oncol Biol Phys 67:1460–1469. doi: 10.1016/j.ijrobp.2006.11.035 PubMedCrossRefGoogle Scholar
  12. Dickie CI, Parent AL, Griffin AM et al (2009) Bone fractures following external beam radiotherapy and limb-preservation surgery for lower extremity soft tissue sarcoma: relationship to irradiated bone length, volume, tumor location and dose. Int J Radiat Oncol Biol Phys 75:1119–1124. doi: 10.1016/j.ijrobp.2008.12.006 PubMedCrossRefGoogle Scholar
  13. Edge SB, Byrd DR, Compton CC et al (2010) American Joint Committee on cancer staging manual 7th edn. Springer, New York, pp 291–300 Google Scholar
  14. Edge SB, Byrd DR, Compton CC et al (2009) American Joint Committee on Cancer (AJCC) cancer staging manual, 7th edn. Springer, BerlinGoogle Scholar
  15. Eilber FC, Brennan MF, Eilber FR et al (2004) Validation of the postoperative nomogram for 12-year sarcoma-specific mortality. Cancer 101:2270–2275. doi: 10.1002/cncr.20570 PubMedCrossRefGoogle Scholar
  16. Farshadpour F, Schaapveld M, Suurmeijer AJH et al (2005) Soft tissue sarcoma: why not treated? Crit Rev Oncol/Hematol 54:77–83. doi: 10.1016/j.critrevonc.2004.10.006 CrossRefGoogle Scholar
  17. Fong Y, Coit DG, Woodruff JM, Brennan MF (1993) Lymph node metastasis from soft tissue sarcoma in adults. Analysis of data from a prospective database of 1772 sarcoma patients. Ann Surg 217:72–77PubMedCentralPubMedCrossRefGoogle Scholar
  18. Hall E, Wuu C (2003) Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 56(1):83–88PubMedCrossRefGoogle Scholar
  19. Helmstedter CS, Goebel M, Zlotecki R, Scarborough MT (2001) Pathologic fractures after surgery and radiation for soft tissue tumors. Clin Orthop Relat Res 389:165–172 Google Scholar
  20. Holt GE, Griffin AM, Pintilie M et al (2005) Fractures following radiotherapy and limb-salvage surgery for lower extremity soft-tissue sarcomas. A comparison of high-dose and low-dose radiotherapy. J Bone Joint Surg Am 87:315–319. doi: 10.2106/JBJS.C.01714 PubMedCrossRefGoogle Scholar
  21. Hong L, Alektiar KM, Hunt M et al (2004) Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh. Int J Radiat Oncol Biol Phys 59:752–759. doi: 10.1016/j.ijrobp.2003.11.037 PubMedCrossRefGoogle Scholar
  22. Kattan MW (2002) Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol 20:791–796. doi: 10.1200/JCO.20.3.791 PubMedCrossRefGoogle Scholar
  23. Levay J, O’sullivan B, Catton C et al (1993) Outcome and prognostic factors in soft tissue sarcoma in the adult. Int J Radiat Oncol Biol Phys 27:1091–1099. doi:  10.1016/0360-3016(93)90529-5 Google Scholar
  24. Lewis JJ, Leung D, Woodruff JM, Brennan MF (1998) Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg 228:355–365PubMedCentralPubMedCrossRefGoogle Scholar
  25. Lin PP, Boland PJ, Healey JH (1998) Treatment of femoral fractures after irradiation. Clin Orthop Relat Res 352:168–178Google Scholar
  26. Mansour JC, Schwarz RE (2009) Pathologic response to preoperative therapy: does it mean what we think it means? Ann Surg Oncol 16:1465–1479. doi: 10.1245/s10434-009-0374-z PubMedCrossRefGoogle Scholar
  27. Mazeron J–J, Suit HD (1987) Lymph nodes as sites of metastases from sarcomas of soft tissue. Cancer 60:1800–1808. doi: 10.1002/1097-0142(19871015)60:8<1800:AID-CNCR2820600822>3.0.CO;2-N PubMedCrossRefGoogle Scholar
  28. Mendenhall WM, Zlotecki RA, Hochwald SN et al (2005) Retroperitoneal soft tissue sarcoma. Cancer 104:669–675. doi: 10.1002/cncr.21264 PubMedCrossRefGoogle Scholar
  29. Nathan H, Raut CP, Thornton K et al (2009) Predictors of survival after resection of retroperitoneal sarcoma: a population-based analysis and critical appraisal of the AJCC staging system. Ann Surg 250:970–976. doi: 10.1097/SLA.0b013e3181b25183 PubMedCentralPubMedCrossRefGoogle Scholar
  30. Novais EN, Demiralp B, Alderete J et al (2010) Do surgical margin and local recurrence influence survival in soft tissue sarcomas? Clin Orthop Relat Res 468:3003–3011. doi: 10.1007/s11999-010-1471-9 PubMedCentralPubMedCrossRefGoogle Scholar
  31. O’Sullivan B, Davis AM, Turcotte R et al (2002) Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet 359:2235–2241. doi: 10.1016/S0140-6736(02)09292-9 PubMedCrossRefGoogle Scholar
  32. O’Sullivan B, Davis AM, Turcotte R et al (2004) Five-year results of a randomized phase III trial of pre-operative vs. post-operative radiotherapy in extremity soft tissue sarcoma. Proc Am Soc Clin Oncol 23:815Google Scholar
  33. Pisters PW, Leung DH, Woodruff J et al (1996) Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol Official J Am Soc Clin Oncol 14:1679–1689Google Scholar
  34. Pisters PWT, Pollock RE, Lewis VO et al (2007) Long-term results of prospective trial of surgery alone with selective use of radiation for patients with T1 extremity and trunk soft tissue sarcomas. Ann Surg 246:675–681; discussion 681–2. doi:  10.1097/SLA.0b013e318155a9ae Google Scholar
  35. Rosenberg SA, Tepper J, Glatstein E et al (1982) The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg 196:305–315PubMedCentralPubMedCrossRefGoogle Scholar
  36. Rydholm A, Gustafson P, Rööser B et al (1991) Limb-sparing surgery without radiotherapy based on anatomic location of soft tissue sarcoma. J Clin Oncol Official J Am Soc Clin Oncol 9:1757–1765Google Scholar
  37. Sabolch A, Feng M, Griffith K et al (2012) Risk factors for local recurrence and metastasis in soft tissue sarcomas of the extremity. Am J Clin Oncol 35:151–157. doi: 10.1097/COC.0b013e318209cd72 PubMedCrossRefGoogle Scholar
  38. Salas S, Stoeckle E, Collin F et al (2009) Superficial soft tissue sarcomas (S-STS): a study of 367 patients from the French sarcoma group (FSG) database. Eur J Cancer 45:2091–2102 (Oxford, England: 1990). doi:  10.1016/j.ejca.2009.03.006 Google Scholar
  39. SEER Database, NCI. In: Surveillance, epidemiology and end results (SEER) program, National Cancer Institute.
  40. Shah D, Borys D, Martinez SR et al (2012) Complete pathologic response to neoadjuvant radiotherapy is predictive of oncological outcome in patients with soft tissue sarcoma. Anticancer Res 32:3911–3915PubMedGoogle Scholar
  41. Singer S, Antonescu CR, Riedel E, Brennan MF (2003) Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg 238:358–370; discussion 370–1. doi:  10.1097/01.sla.0000086542.11899.38 Google Scholar
  42. Stoeckle E, Coindre JM, Bonvalot S et al (2001) Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French cancer center federation sarcoma group. Cancer 92:359–368PubMedCrossRefGoogle Scholar
  43. Stojadinovic A, Leung DHY, Hoos A et al (2002) Analysis of the prognostic significance of microscopic margins in 2,084 localized primary adult soft tissue sarcomas. Ann Surg 235:424–434PubMedCentralPubMedCrossRefGoogle Scholar
  44. Suit HD, Mankin HJ, Wood WC et al (1988) Treatment of the patient with stage M0 soft tissue sarcoma. J Clin Oncol Official J Am Soc Clin Oncol 6:854–862Google Scholar
  45. Willett CG, Schiller AL, Suit HD et al (1987) The histologic response of soft tissue sarcoma to radiation therapy. Cancer 60:1500–1504PubMedCrossRefGoogle Scholar
  46. Zagars GK, Ballo MT, Pisters PWT et al (2003a) Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients. Cancer 97:2530–2543. doi: 10.1002/cncr.11365 PubMedCrossRefGoogle Scholar
  47. Zagars GK, Ballo MT, Pisters PWT et al (2003b) Prognostic factors for disease-specific survival after first relapse of soft-tissue sarcoma: analysis of 402 patients with disease relapse after initial conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys 57:739–747PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  1. 1.Department of Radiation Oncology, Abramson Cancer CenterHospital of the University of PennsylvaniaPhiladelphiaUSA
  2. 2.Connective Tissue Oncology Center, Francis H. Burr Proton Therapy Center, Radiation OncologyMassachusetts General HospitalBostonUSA

Personalised recommendations